1-[2-(1,2-diazaspiro[2.5]oct-1-yl)ethyl]-1,2-diazaspiro[2.5]octane | 1076240-90-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-[2-(1,2-diazaspiro[2.5]oct-1-yl)ethyl]-1,2-diazaspiro[2.5]octane
• 英文别名: 2-[2-(1,2-Diazaspiro[2.5]octan-2-yl)ethyl]-1,2-diazaspiro[2.5]octane
• CAS: 1076240-90-8
• 化学式: C₁₄H₂₆N₄
• 分子量: 250.387
• InChiKey: ZIMFLOAYZTYCIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  49.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-[2-(1,2-diazaspiro[2.5]oct-1-yl)ethyl]-1,2-diazaspiro[2.5]octane 、 cadmium(II) nitrate tetrhydrate 以 乙腈 为溶剂， 以76%的产率得到(dinitrato)(diaqua)[1,2-bis(1,2-diazaspiro[2.5]oct-1-yl)ethane]cadmium(II)
  参考文献：
  名称：

  Complexes of αω-bis(3,3-dialkyldiaziridin-1-yl)alkanes and their bis(2-arylcarbamoyl) derivatives with cadmium and nickel salts

  摘要：

  合成了αω-双(3,3-二烷基二氮丙啶-1-基)烷烃及其双(2-芳基氨基甲酰基)衍生物与 Cd2+ 和 Ni2+ 盐的络合物。X 射线衍射研究表明，起始双氮丙啶只有一个分子参与了络合。Cd2+ 复合物具有八面体几何形状。Ni2+ 复合物为方形或八面体。其中一种八面体 Ni2+ 复合物在手性空间群 P21 中结晶。

  DOI：

  10.1007/s11172-008-0008-9
• 作为产物：
  描述：

  cyclohexanone O-4-toluenesulfonyl oxime 、 乙二胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以34.2%的产率得到1-[2-(1,2-diazaspiro[2.5]oct-1-yl)ethyl]-1,2-diazaspiro[2.5]octane
  参考文献：
  名称：

  Synthesis and structure of 1-[ω-(3,3-dialkyldiaziridin-1-yl)alkyl]-3,3-dialkyldiaziridines

  摘要：

  建立了一种基于酮肟邻芳烃磺酸盐与亚烷基二胺反应合成1-[ω-(3,3-二烷基二氮丙啶-1-基)烷基]-3,3-二烷基二氮丙啶的方法。分离出1-[2-(3,3-二甲基二氮丙啶-1-基)乙基]-3,3-二甲基二氮丙啶的非对映异构体（外消旋和内消旋形式）。通过X射线衍射分析证实了内消旋形式的结构。

  DOI：

  10.1007/s11172-007-0241-7

文献信息

• DIAZARIDINE DERIVATIVES FOR TREATING METAL DISORDERS
  申请人：Pharmdiscovery LLP

  公开号：EP2621906A1

  公开（公告）日：2013-08-07
• AGENTS FOR TREATING NEURODEGENERATIVE DISORDERS
  申请人：Pharmdiscovery LLP

  公开号：US20140088063A1

  公开（公告）日：2014-03-27

  The present invention relates to compounds of formula (I) or (I′), use of these compounds to treat mental disorders, especially depressions of different etiology, and methods for their preparation. The compounds that are provided for the treatment of mental disorders can be presented by a general formula (I) as meso-form—S,2S,1′R,2′R-1-[ω-(3,3-dialkyldiaziridin-1-yl)alkyl]-3,3-dialkyldiaziridines: wherein R, X and n are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds, with the proviso that the compound of Formula (I) is not meso-1S,2S,1′R,2′R-1-[2-(3,3-dimethyldiaziridin-1-yl)ethyl]-3,3-dimethyldiaziridine (R═Me, X═CH2, n=2) (Formula I′).
• [EN] DIAZARIDINE DERIVATIVES FOR TREATING METAL DISORDERS<br/>[FR] DÉRIVÉS DE DIAZARIDINE UTILES DANS LE TRAITEMENT DES TROUBLES MENTAUX
  申请人：PHARMDISCOVERY LLP

  公开号：WO2012042502A1

  公开（公告）日：2012-04-05

  The present invention relates to compounds of formula (I) or (la), use of these compounds to treat mental disorders, especially depressions of different etiology, and methods for their preparation. The compounds that are provided for the treatment of mental disorders can be presented by a general formula (I) as meso-form -S,2S,1'R,2'R-1-[ω-(3,3-dialkyldiaziridin-1-yl)alkyl] -3,3-dialkyldiaziridines: wherein R, X and n are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds, with the proviso that the compound of Formula (I) is not meso-1S,2S,1'R,2'R-1-[2-(3,3-dimethyldiaziridin-1-yl)ethyl]-3,3-dimethyldiaziridine (R=Me, X=CH2, n=2) (Formula la).
• Synthesis and structure of 1-[ω-(3,3-dialkyldiaziridin-1-yl)alkyl]-3,3-dialkyldiaziridines
  作者：V. Yu. Petukhova、Yu. A. Strelenko、K. A. Lyssenko、N. N. Makhova

  DOI：10.1007/s11172-007-0241-7

  日期：2007.8

  A method for the synthesis of 1-[ω-(3,3-dialkyldiaziridin-1-yl)alkyl]-3,3-dialkyldiaziridines based on the reaction of ketoxime O-arenesulfonates with alkylenediamines was developed. Diastrereomers (the racemic and meso forms) of 1-[2-(3,3-dimethyldiaziridin-1-yl)ethyl]-3,3-dimethyldiaziridine were isolated. The structure of the meso form was confirmed by X-ray diffraction analysis.

  建立了一种基于酮肟邻芳烃磺酸盐与亚烷基二胺反应合成1-[ω-(3,3-二烷基二氮丙啶-1-基)烷基]-3,3-二烷基二氮丙啶的方法。分离出1-[2-(3,3-二甲基二氮丙啶-1-基)乙基]-3,3-二甲基二氮丙啶的非对映异构体（外消旋和内消旋形式）。通过X射线衍射分析证实了内消旋形式的结构。
• Complexes of αω-bis(3,3-dialkyldiaziridin-1-yl)alkanes and their bis(2-arylcarbamoyl) derivatives with cadmium and nickel salts
  作者：T. V. Skrupskaya、A. A. Kislukhin、A. V. Shevtsov、V. Yu. Petukhova、K. A. Lyssenko、N. N. Makhova

  DOI：10.1007/s11172-008-0008-9

  日期：2008.1

  Complexes of αω-bis(3,3-dialkyldiaziridin-1-yl)alkanes and their bis(2-arylcarbamoyl) derivatives with Cd2+ and Ni2+ salts were synthesized. The X-ray diffraction study showed that only one molecule of the starting bis-diaziridine is involved in the complexation. The Cd2+ complexes have octahedral geometry. The Ni2+ complexes are either square-planar or octahedral. One of the octahedral Ni2+ complexes crystallizes in the chiral space group P21.

  合成了αω-双(3,3-二烷基二氮丙啶-1-基)烷烃及其双(2-芳基氨基甲酰基)衍生物与 Cd2+ 和 Ni2+ 盐的络合物。X 射线衍射研究表明，起始双氮丙啶只有一个分子参与了络合。Cd2+ 复合物具有八面体几何形状。Ni2+ 复合物为方形或八面体。其中一种八面体 Ni2+ 复合物在手性空间群 P21 中结晶。